1h Free Analyst Time
The herpes treatment market is poised to grow by $920.28 mn during 2023-2027, decelerating at a CAGR of 3.76% during the forecast period. The report on the herpes treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of herpes infection, the large patient pool, and the rising prevalence rate of shingles in older population.
The herpes treatment market is segmented as below:
By Product
- Vaccination
- Drug therapy
By Type
- Herpes zoster
- Herpes simplex
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the herpes treatment market covers the following areas:
- Herpes treatment market sizing
- Herpes treatment market forecast
- Herpes treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global herpes treatment market: AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet Pharmaceuticals Inc., Cadila Healthcare Ltd., CENTURION REMEDIES Pvt. Ltd., Cipla Ltd., Eli Lilly and Co., Fresenius SE and Co. KGaA, Gilead Sciences Inc., GlaxoSmithKline Plc, Maruho Co. Ltd., Merck and Co. Inc., Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Zeelab Laboratories Ltd., and Bausch Health Co Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the emergence of novel therapies.`
According to the report, one of the major drivers for this market is the increasing prevalence of herpes infection.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- AiCuris Anti infective Cures AG
- Aurobindo Pharma Ltd.
- Avet Pharmaceuticals Inc.
- Cadila Healthcare Ltd.
- CENTURION REMEDIES Pvt. Ltd.
- Cipla Ltd.
- Eli Lilly and Co.
- Fresenius SE and Co. KGaA
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Maruho Co. Ltd.
- Merck and Co. Inc.
- Novartis AG
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Zeelab Laboratories Ltd.
- Bausch Health Co Inc.
